Compare AANJANEYA LIFECARE with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NATCO PHARMA DR. DATSONS LABS/
NATCO PHARMA
 
P/E (TTM) x -10.9 15.7 - View Chart
P/BV x 0.2 3.1 5.3% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 DR. DATSONS LABS   NATCO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NATCO PHARMA
Mar-18
DR. DATSONS LABS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,080 11.6%   
Low Rs31671 4.6%   
Sales per share (Unadj.) Rs133.0592.1 22.5%  
Earnings per share (Unadj.) Rs0.2188.4 0.1%  
Cash flow per share (Unadj.) Rs6.6206.3 3.2%  
Dividends per share (Unadj.) Rs08.25 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8833.6 15.4%  
Shares outstanding (eoy) m31.6636.90 85.8%   
Bonus/Rights/Conversions FCCBIS-  
Price / Sales ratio x0.61.5 39.8%   
Avg P/E ratio x516.14.6 11,104.7%  
P/CF ratio (eoy) x11.84.2 279.1%  
Price / Book Value ratio x0.61.1 57.8%  
Dividend payout %04.4 0.0%   
Avg Mkt Cap Rs m2,47732,311 7.7%   
No. of employees `000NA4.8 0.0%   
Total wages/salary Rs m563,256 1.7%   
Avg. sales/employee Rs ThNM4,522.5-  
Avg. wages/employee Rs ThNM674.0-  
Avg. net profit/employee Rs ThNM1,439.0-  
INCOME DATA
Net Sales Rs m4,21121,848 19.3%  
Other income Rs m79404 19.5%   
Total revenues Rs m4,28922,252 19.3%   
Gross profit Rs m5699,284 6.1%  
Depreciation Rs m204662 30.9%   
Interest Rs m430154 279.4%   
Profit before tax Rs m138,872 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,920 0.3%   
Profit after tax Rs m56,952 0.1%  
Gross profit margin %13.542.5 31.8%  
Effective tax rate %48.021.6 221.9%   
Net profit margin %0.131.8 0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85221,307 32.2%   
Current liabilities Rs m6,7115,920 113.4%   
Net working cap to sales %3.370.4 4.8%  
Current ratio x1.03.6 28.4%  
Inventory Days Days16173 219.6%  
Debtors Days Days318107 299.0%  
Net fixed assets Rs m3,67314,986 24.5%   
Share capital Rs m317369 85.8%   
"Free" reserves Rs m3,76130,353 12.4%   
Net worth Rs m4,07830,760 13.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63337,151 34.0%  
Interest coverage x1.058.6 1.8%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.6 56.7%   
Return on assets %3.419.1 18.0%  
Return on equity %0.122.6 0.5%  
Return on capital %7.729.3 26.2%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96410,322 9.3%   
Fx outflow Rs m6072,978 20.4%   
Net fx Rs m3577,343 4.9%   
CASH FLOW
From Operations Rs m1,3454,636 29.0%  
From Investments Rs m-2,256-11,155 20.2%  
From Financial Activity Rs m-1,2006,509 -18.4%  
Net Cashflow Rs m-2,111-18 11,726.1%  

Share Holding

Indian Promoters % 4.5 52.0 8.7%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 1.4 16.6 8.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.0 361.9%  
Shareholders   20,807 25,395 81.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  PFIZER  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS